Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Fate Therapeutics (FATE) Asset Utilization Ratio (2016 - 2025)

Historic Asset Utilization Ratio for Fate Therapeutics (FATE) over the last 13 years, with Q3 2025 value amounting to 0.02.

  • Fate Therapeutics' Asset Utilization Ratio fell 2403.56% to 0.02 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.02, marking a year-over-year decrease of 2403.56%. This contributed to the annual value of 0.03 for FY2024, which is 7254.37% down from last year.
  • As of Q3 2025, Fate Therapeutics' Asset Utilization Ratio stood at 0.02, which was down 2403.56% from 0.02 recorded in Q2 2025.
  • Fate Therapeutics' Asset Utilization Ratio's 5-year high stood at 0.2 during Q1 2023, with a 5-year trough of 0.01 in Q1 2024.
  • For the 5-year period, Fate Therapeutics' Asset Utilization Ratio averaged around 0.08, with its median value being 0.05 (2021).
  • As far as peak fluctuations go, Fate Therapeutics' Asset Utilization Ratio surged by 18889.29% in 2023, and later crashed by 9412.43% in 2024.
  • Fate Therapeutics' Asset Utilization Ratio (Quarter) stood at 0.06 in 2021, then soared by 125.9% to 0.13 in 2022, then decreased by 8.58% to 0.12 in 2023, then tumbled by 75.92% to 0.03 in 2024, then plummeted by 31.51% to 0.02 in 2025.
  • Its Asset Utilization Ratio was 0.02 in Q3 2025, compared to 0.02 in Q2 2025 and 0.03 in Q1 2025.